Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms

Schizophrenia Research

Volumn 14, Issue 2, 1995, Pages 93-104

  Prell, George D ^a   Green, Jack Peter ^a   Kaufmann, Charles A ^b   Khandelwal, Jai K ^a   Morrishow, Albert M ^a   Kirch, Darrell G ^b   Linnoila, Markku ^c   Wyatt, Richard Jed ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

(Schizophrenia); Cerebrospinal fluid; Histamine metabolite

Indexed keywords

1 METHYL 4(5) IMIDAZOLEACETIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; HISTAMINE; HOMOVANILLIC ACID; NEUROLEPTIC AGENT; NORADRENALIN; TELE METHYLHISTAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BIOGENIC AMINES; CHRONIC DISEASE; DYSKINESIA, DRUG-INDUCED; FEMALE; HISTAMINE; HUMAN; IMIDAZOLES; MALE; METHYLHISTAMINES; MIDDLE AGE; NEUROTRANSMITTERS; NOREPINEPHRINE; PSYCHIATRIC STATUS RATING SCALES; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028821071     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(94)00034-6     Document Type: Article

References (96)

1. Interacting neurotransmitter systems: a non-experimental approach to the 5-HIAA-HVA correlation in human CSF
2. Determination of histamine in cerebrospinal fluid in some neuropsychiatric cases
3. Neurochemistry of cerebrospinal fluid in normal individuals
4. 2 antagonist famotidine: in vitro studies
5. The psychiatric symptom assessment scale (PSAS)
6. Different localization of histidine decarboxylase and histamine-N-methyltransferase in the rat brain
7. 2 receptor in the rat hypothalamus releases endogenous norepinephrine
8. Desensitization of histamine Hl receptormediated inositol phosphate accumulation in guinea pig cerebral cortex slices
9. Distribution and properties of a histamine-methylating enzyme
10. Histaminergic system: neuroendocrine function of brain histamine
11. Monoamine mechanisms in chronic schizophrenia, post-mortem neurochemical findings
12. Famotidine adjunctive pharmacotherapy of schizophrenia: preliminary data
13. Homologous desensitization of muscarinic cholinergic, histaminergic, adrenergic, and serotonergic receptors coupled to phospholipase C in cerebellar granule cells.
14. Processing data for outliers
15. Brain histamine as neuroendocrine transmitter
16. Brainstem afferents to the tuberomammillary nucleus in the rat brain with special reference to monoaminergic innervation
17. Differential effects of histamine on the activity of hypothalamic dopaminergic neurons in the rat
18. Histamine and the nervous system
19. Histamine
20. Histamine receptors in brain
21. Histamine receptors
22. Histamine turnover in regions of rat brain
23. Histamine as a neurotransmitter
24. Aspects of histamine metabolism
25. Modulation of histamine release and synthesis in the brain mediated by a2-adrenoceptors
26. 2-Adrenoceptor-mediated inhibition of histamine release from rat cerebral cortical slices
27. Cellular localization and possible functions for brain histamine: recent progress
28. Tele-methylhistamine oxidation by type B monoamine oxidase
29. Histamine and its receptors in the nervous system
30. Gas chromatography-mass spectrometric characteristics and assay of tele-methylhistamine
31. An improved GCMS method to measure telemethylhistamine
32. Histamine turnover in regions of rat brain
33. Inhibition of brain histamine metabolism by metoprine
34. Famotidine: A notable lack of drug interactions
35. CSF concentrations of famotidine
36. Effect of famotidine on deficit symptoms of schizophrenia
37. Effects of famotidine a histamine Hz-receptor antagonist on negative symptoms of schizophrenia
38. Presence and measurement of methylimidazoleactic acids in brain and body fluids
39. Regional distribution of the histamine metabolite, telemethylimidazoleacetic acid, in rat brain: effects of pargyline and probenecid
40. Histamine- and stress-induced secretion of ACTH and β-endorphin involvement of corticotropin-releasing hormone and vasopressin
41. 3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF concentrations of MHPG
42. Famotidine: an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases
43. A sensitive and specific method for the determination of histamine in human whole blood and plasma
44. Acute effects of histamine in psychiatric patients
45. Histamine tolerance in schizophrenia
46. Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates
47. Decreased histamine Hl receptors in the frontal cortex of brains from patients with chronic schizophrenia
48. Regional differences in the turnover of neuronal histamine in the rat brain
49. The brief psychiatric rating scale
50. Selective decreases in MAO-B activity in post-mortem brains from schizophrenic patients with type II syndrome
51. Famotidine as an adjunct treatment of resistant schizophrenia
52. A histamine-containing neuronal system in human brain
53. In vivo release by histamine agonists and antagonists of endogenous catecholamines in the cat hypothalamus
54. Influence of histamine on the serotonergic system of rat brain
55. Modulation by dopamine receptors of the histamine release in the rat hypothalamus
56. Histamine as a neuroregulator
57. Measurement of histamine metabolites in brain and cerebrospinal fluid provides insights into histaminergic activity
58. Histamine metabolites in cerebrospinal fluid of the rhesus monkey (Macaca mulatta): cistemal-lumbar concentration gradients
59. Elevated levels of histamine metabolites in cerebrospinal fluid of aging, healthy humans
60. Rostral-caudal concentration gradients of histamine metabolites in human cerebrospinal fluid
61. pros-Methylimidazoleacetic acid in rat brain: its regional distribution and relationship to metabolic pathways of histamine
62. Diurnal fluctuations in levels of histamine metabolites in cerebrospinal fluid of rhesus monkey
63. Influence of age and gender on the levels of histamine metabolites and pros-methylimidazoleacetic acid in human cerebrospinal fluid
64. Levels of prosmethylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice
65. Specific desensitization of histamine H, receptormediated [3H]glycogen hydrolysis in brain slices
66. Histamine and schizophrenia
67. Cutaneous histamine response in schizophrenia
68. Psychotherapeutic drugs, histamine H, and muscarinic acetylcholine receptors
69. The presence of imidazoleacetic acid riboside and imidazoleacetic acid ribotide in rat tissues
70. Contemporary physiodynamic therapeutic trends in psychiatry
71. The technique of histamine biochemotherapy and suggestions for its use in psychiatry
72. Effect of propranolol on monoamine metabolites in CSF of patients with chronic schizophrenia
73. Catabolism of 3H-histamine in the rat brain after intracisternal administration
74. Histaminergic transmission in the mammalian brain
75. Multiple forms of brain monoamine oxidase in schizophrenic and normal individuals
76. An analysis of variance test for normality (complete samples)
77. 14C-histamine in animal tissues
78. Histamine in the brain: A neurotransmitter?
79. Research diagnostic criteria-rationale and reliability
80. The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumption
81. 4-Methylhistamine is a specific substrate for type B monoamine oxidase
82. Identification and determination of tele-methylhistamine in cerebrospinal fluid by gas chromatography-mass spectrometry
83. Identification and determination of 1-methylimidazole-4-acetic acid in human cerebrospinal fluid by gas chromatography-mass spectrometry
84. Histamine metabolites in cerebrospinal fluid, the rationale for studying them and analytical aspects
85. Desensitization of histamine H, receptor-mediated cyclic GMP formation in mouse neuroblastoma cells
86. Neurotransmitter regulation of anterior pituitary hormones
87. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis
88. Is the histaminergic neuron system a regulatory center for whole-brain activity?
89. Methylhistamine: evidence for selective deamination by MAO B in the rat brain in vivo
90. Role of brain monoamines and histamine in regulation of anterior pituitary secretion
91. Evaluation of dopamine metabolism in rat striatum by a gas chromatographic technique
92. Biochemical and sleep studies of schizophrenia a review of the literature-1960–1970